PubRank

Soy, Selenium and Breast Cancer Risk

Clinical Trial ID NCT00555386

PubWeight™ 2.29‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00555386

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981 25.60
2 Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967 16.75
3 Estrogen and the risk of breast cancer. N Engl J Med 2001 4.39
4 Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994 3.25
5 Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006 2.79
6 Lessons from basic research in selenium and cancer prevention. J Nutr 1998 2.27
7 Independent validation of candidate breast cancer serum biomarkers identified by mass spectrometry. Clin Chem 2005 2.13
8 Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer 2005 1.84
9 Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium. Cancer Res 2003 1.76
10 Selenium and its relationship to cancer: an update. Br J Nutr 2004 1.66
11 Nutritional aspects of the development of cancer. Report of the Working Group on Diet and Cancer of the Committee on Medical Aspects of Food and Nutrition Policy. Rep Health Soc Subj (Lond) 1998 1.62
12 Soy for breast cancer survivors: a critical review of the literature. J Nutr 2001 1.43
13 IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2006 1.39
14 Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B Analyt Technol Biomed Life Sci 2004 1.35
15 BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells. Br J Cancer 2006 1.27
16 Application of biofluid 1H nuclear magnetic resonance-based metabonomic techniques for the analysis of the biochemical effects of dietary isoflavones on human plasma profile. Anal Biochem 2003 1.24
17 Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 1999 1.24
18 Selenium and mortality in the elderly: results from the EVA study. Clin Chem 2005 1.24
19 Targeting Akt3 signaling in malignant melanoma using isoselenocyanates. Clin Cancer Res 2009 1.22
20 Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics. Cancer Treat Rev 2009 1.13
21 Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br J Nutr 1995 1.10
22 Premenopausal equol excretors show plasma hormone profiles associated with lowered risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2000 1.08
23 Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998 1.06
24 Selenium and cancer chemoprevention: hypotheses integrating the actions of selenoproteins and selenium metabolites in epithelial and non-epithelial target cells. Antioxid Redox Signal 2005 1.03
25 Biofluid 1H NMR-based metabonomic techniques in nutrition research - metabolic effects of dietary isoflavones in humans. J Nutr Biochem 2005 1.00
26 Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat Res 2004 1.00
27 The initiation of breast and prostate cancer. Carcinogenesis 2002 0.97
28 Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol 2002 0.97
29 Selenium disrupts estrogen receptor (alpha) signaling and potentiates tamoxifen antagonism in endometrial cancer cells and tamoxifen-resistant breast cancer cells. Mol Cancer Ther 2005 0.95
30 Phytoestrogens and breast cancer. Baillieres Clin Endocrinol Metab 1998 0.94
31 Synergy between sulforaphane and selenium in the induction of thioredoxin reductase 1 requires both transcriptional and translational modulation. Carcinogenesis 2003 0.87
32 Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells. Cancer Res 2005 0.87
33 Dietary factors modifying breast cancer risk and relation to time of intake. J Mammary Gland Biol Neoplasia 2005 0.83
34 A comparative study of growth-inhibitory effects of isoflavones and their metabolites on human breast and prostate cancer cell lines. Nutr Cancer 2002 0.79
35 Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD. Anticancer Res 2000 0.77
Next 100